IL312774A - Multicyclic compounds - Google Patents
Multicyclic compoundsInfo
- Publication number
- IL312774A IL312774A IL312774A IL31277424A IL312774A IL 312774 A IL312774 A IL 312774A IL 312774 A IL312774 A IL 312774A IL 31277424 A IL31277424 A IL 31277424A IL 312774 A IL312774 A IL 312774A
- Authority
- IL
- Israel
- Prior art keywords
- multicyclic compounds
- multicyclic
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163279094P | 2021-11-13 | 2021-11-13 | |
| US202163282264P | 2021-11-23 | 2021-11-23 | |
| US202263299749P | 2022-01-14 | 2022-01-14 | |
| US202263317980P | 2022-03-09 | 2022-03-09 | |
| US202263321915P | 2022-03-21 | 2022-03-21 | |
| US202263336476P | 2022-04-29 | 2022-04-29 | |
| US202263375050P | 2022-09-08 | 2022-09-08 | |
| PCT/US2022/049719 WO2023086580A2 (en) | 2021-11-13 | 2022-11-11 | Multicyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL312774A true IL312774A (en) | 2024-07-01 |
Family
ID=86336491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL312774A IL312774A (en) | 2021-11-13 | 2022-11-11 | Multicyclic compounds |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250100987A1 (https=) |
| EP (1) | EP4429656A4 (https=) |
| JP (1) | JP2024543479A (https=) |
| CA (1) | CA3238026A1 (https=) |
| IL (1) | IL312774A (https=) |
| WO (1) | WO2023086580A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024226703A2 (en) * | 2023-04-27 | 2024-10-31 | The Scripps Research Institute | Asymmetric synthesis and diversification of a stabilized salvinorin a scaffold |
| CN118267384B (zh) * | 2024-03-27 | 2024-12-20 | 徐州医科大学 | κ阿片受体激动剂在制备预防和/或治疗颞叶癫痫药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090088466A1 (en) * | 2005-06-17 | 2009-04-02 | University Of Iowa Research Foundation | Opioid receptor ligands |
| US11512075B2 (en) * | 2017-06-14 | 2022-11-29 | The Scripps Research Institute | Synthesis of 20-nor-salvinorin A |
| US20210186927A1 (en) * | 2018-04-13 | 2021-06-24 | Blumentech, S.L. | Combination product for the induction and/or maintenance of general anesthesia |
| US10556889B1 (en) * | 2018-12-19 | 2020-02-11 | Blue Sky Pharmaceuticals, LLC | Salvinorin derivatives |
-
2022
- 2022-11-11 IL IL312774A patent/IL312774A/en unknown
- 2022-11-11 CA CA3238026A patent/CA3238026A1/en active Pending
- 2022-11-11 EP EP22893676.1A patent/EP4429656A4/en active Pending
- 2022-11-11 WO PCT/US2022/049719 patent/WO2023086580A2/en not_active Ceased
- 2022-11-11 US US18/707,895 patent/US20250100987A1/en active Pending
- 2022-11-11 JP JP2024528455A patent/JP2024543479A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023086580A3 (en) | 2023-07-06 |
| JP2024543479A (ja) | 2024-11-21 |
| WO2023086580A2 (en) | 2023-05-19 |
| EP4429656A2 (en) | 2024-09-18 |
| CA3238026A1 (en) | 2023-05-19 |
| US20250100987A1 (en) | 2025-03-27 |
| EP4429656A4 (en) | 2026-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK4165024T3 (da) | Cyclobutyldihydroquinolinsulfonamid-forbindelser | |
| EP4129997A4 (en) | Octahydropyrazinodiazanaphthyridine dione compounds | |
| EP4186256C0 (en) | INTER-AGENCY COMMUNICATION VIA AN AD-HOC NETWORK SLICE | |
| IL310528A (en) | Pyrazolopyridinone compounds | |
| EP4137404A4 (en) | Multicopter | |
| EP4149556C0 (en) | PEG LIPIDOIDS COMPOUNDS | |
| DK4320112T3 (da) | Pyridinylsubstituerede oxoisoindolinforbindelser | |
| EP4222352A4 (en) | BOLTER | |
| EP4107782A4 (en) | MICROARRAYS | |
| EP4272364A4 (en) | TA NTN REPORT | |
| EP4223314A4 (en) | LIPID NANOPARTICLE | |
| EP4143199C0 (en) | NUCLEOTIDE PROMEDICINAL COMPOUNDS | |
| EP3957265A4 (en) | MICROSCOPE COVER | |
| EP4204218C0 (en) | TAPE LAYING HEAD | |
| EP4063561C0 (en) | REFINER SEGMENT | |
| EP4163277C0 (en) | NEW PYRAZOLE DERIVATIVES | |
| IL312774A (en) | Multicyclic compounds | |
| EP4274436A4 (en) | Combination therapies | |
| EP4192823C0 (en) | TRIAZOLES DIFLUOROMETHYL-PYRIDIN-2-YL | |
| EP4433585A4 (en) | NEW OMNI CRISPR NUCLEASE | |
| EP4154884A4 (en) | Anti-sars-cov-2 durg | |
| EP4137402A4 (en) | MULTICOPTER | |
| IL313590A (en) | Compounds | |
| PT4038149T (pt) | Compostos anti-incrustação | |
| EP4228051A4 (en) | LEAD STORAGE BATTERY |